Amyndas Pharmaceuticals S.A.
3 clinical trials · Sponsor
◉ Watch Amyndas Pharmaceuticals S.A.
| Record | Firm | Date |
|---|---|---|
| A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE) (NCT04395456) | Amyndas Pharmaceuticals S.A. | 2021-09-01 |
| A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis (NCT03694444) | Amyndas Pharmaceuticals S.A. | 2019-07-22 |
Track Amyndas Pharmaceuticals S.A. automatically
Every clearance here is in the API, with alerts when new ones post.